Seattle-based Cadence Biomedical, manufacturer of the Kickstart Walking System, announces that funding has been secured to study the effects of the Kickstart system on stroke survivors.
In a news release, the company notes that its research collaborators from the Université de Montréal and the Center for Interdisciplinary Research in Rehabilitation of Greater Montreal secured this grant from the Physiotherapy Foundation of Canada and the Quebec Rehabilitation Research Network.
Dany Gagnon, PT, PhD, of the Université de Montréal is the principal investigator on the grant, titled “Effects of a Novel Elasticity-Based Lower Limb Assistive Exoskeleton on Walking and Walking-Related Abilities in Individuals with Post-Stroke Hemiparesis and Users’ Satisfaction,” and will lead a team of collaborators from his institution and McGill University.
Cadence COO Brian Glaister will also serve as a co-investigator on this grant, according to the release.
The Cadence release explains that the Kickstart Walking System is an orthotic device that helps provide stability and movement assistance to weakened muscles without the use of powered mechanisms.
“At Université de Montréal we are very interested in studying mobility assistive technologies such as Kickstart. The end goal is to help patients accelerate their recovery and reduce healthcare costs while improving the quality of life for stroke survivors,” Gagnon states, in the release.
“Stroke is a rapidly growing global concern. We are very grateful to be working with Dr Gagnon and his world-renowned research team to further investigate Kickstart’s ability to help stroke survivors recover to walking,” Glaister says.
For more information, visit Cadence Biomedical.
[Source: Cadence Biomedical]